SPI
18.353,79
PKT
-265,93
PKT
-1,43
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.04.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 07.04.22 | ams-OSRAM Hold | Deutsche Bank AG | |
| 06.04.22 | Nestlé Buy | UBS AG | |
| 06.04.22 | ams-OSRAM Neutral | UBS AG | |
| 06.04.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 06.04.22 | Nestlé Overweight | Barclays Capital | |
| 06.04.22 | ams-OSRAM Underweight | Barclays Capital | |
| 06.04.22 | ams-OSRAM Hold | Jefferies & Company Inc. | |
| 05.04.22 | UBS Outperform | RBC Capital Markets | |
| 05.04.22 | UBS Sector Perform | RBC Capital Markets | |
| 05.04.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 05.04.22 | ams-OSRAM Neutral | UBS AG | |
| 05.04.22 | Novartis Sell | Deutsche Bank AG | |
| 05.04.22 | Richemont Overweight | JP Morgan Chase & Co. | |
| 04.04.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 04.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.04.22 | Richemont Buy | UBS AG | |
| 04.04.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 04.04.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 01.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 01.04.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 01.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 01.04.22 | UBS Outperform | Credit Suisse Group | |
| 31.03.22 | DocMorris Sell | UBS AG | |
| 31.03.22 | Roche Buy | Deutsche Bank AG | |
| 31.03.22 | ams-OSRAM Overweight | JP Morgan Chase & Co. | |
| 31.03.22 | UBS Neutral | Goldman Sachs Group Inc. | |
| 31.03.22 | UBS Buy | Goldman Sachs Group Inc. | |
| 30.03.22 | Nestlé Neutral | Credit Suisse Group | |
| 30.03.22 | Roche Overweight | Barclays Capital | |
| 30.03.22 | Roche Buy | Merrill Lynch & Co., Inc. | |
| 30.03.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 30.03.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.03.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 30.03.22 | Roche Outperform | Bernstein Research | |
| 30.03.22 | UBS Sector Perform | RBC Capital Markets | |
| 30.03.22 | UBS Outperform | RBC Capital Markets | |
| 30.03.22 | Peach Property Group Kaufen | SRC Research GmbH | |
| 30.03.22 | UBS Buy | Jefferies & Company Inc. |